Stroke Alert October 2022

<p>On Episode 21 of the <em>Stroke Alert</em> Podcast, host Dr. Negar Asdaghi highlights two articles from the October 2022 issue of <em>Stroke</em>: “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.038659">Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk</a>” and “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.038752">Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage</a>.” She also interviews Dr. Shadi Yaghi about his article “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.039579">Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis</a>.”</p> <p>Dr. Negar Asdaghi:         Let's start with some questions.</p> <p>1) Do hormone replacement therapies or oral contraceptives increase the risk of stroke? And if yes, does the age of the individual or the duration of therapy modify this risk?</p> <p>2) Should survivors of intracranial hemorrhage who have atrial fibrillation be treated with antithrombotic therapies for secondary prevention of stroke?</p> <p>3) And finally, what is the anticoagulant of choice for treatment of cerebral venous sinus thrombosis?</p> <p>We have the answers and much more in today's podcast as we continue to bring you the latest in cerebrovascular disorders. You're listening to the <em>Stroke Alert</em> Podcast, and this is the best in <em>Stroke</em>. Stay with us.</p> <p>Welcome back to another amazing issue of the <em>Stroke Alert</em> Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine, and your host for the monthly <em>Stroke Alert</em> Podcast. The October issue of <em>Stroke</em> covers a number of timely topics. As part of our <a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.040566">October Literature Synopsis</a>, we have a nice paper by Dr. Farida Sohrabji and colleague, which summarizes three recently published animal studies to